Index - P/E - EPS (ttm) -0.44 Insider Own 56.52% Shs Outstand 166.66M Perf Week 1.86%
Market Cap 4.55B Forward P/E - EPS next Y - Insider Trans 0.01% Shs Float 72.47M Perf Month 4.31%
Income -73.52M PEG - EPS next Q 0.11 Inst Own 47.90% Short Float 1.29% Perf Quarter 26.12%
Sales 863.29M P/S 5.28 EPS this Y - Inst Trans - Short Ratio 1.44 Perf Half Y -
Book/sh 17.68 P/B 1.55 EPS next Y - ROA -1.59% Short Interest 0.94M Perf Year -
Cash/sh 0.48 P/C 56.61 EPS next 5Y - ROE -2.92% 52W Range 20.26 - 28.57 Perf YTD 32.03%
Dividend Est. - P/FCF 1668.43 EPS past 5Y - ROI -1.71% 52W High -4.34% Beta -
Dividend TTM - Quick Ratio 2.15 Sales past 5Y 17.03% Gross Margin 46.42% 52W Low 34.90% ATR (14) 0.83
Dividend Ex-Date - Current Ratio 2.15 EPS Y/Y TTM -83.72% Oper. Margin 14.14% RSI (14) 63.71 Volatility 3.36% 2.84%
Employees - Debt/Eq 0.47 Sales Y/Y TTM 15.55% Profit Margin -8.52% Recom 1.20 Target Price 29.89
Option/Short Yes / Yes LT Debt/Eq 0.46 EPS Q/Q -155.93% Payout - Rel Volume 14.65 Prev Close 27.01
Sales Surprise 8.46% EPS Surprise 368.46% Sales Q/Q 19.68% Earnings Aug 07 AMC Avg Volume 651.22K Price 27.33
SMA20 2.32% SMA50 10.46% SMA200 15.01% Trades
Volume 9,538,278 Change 1.18%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-02-24 Initiated William Blair
Outperform
Jul-02-24 Initiated RBC Capital Mkts
Outperform
$27
Jul-02-24 Initiated Raymond James
Outperform
$30
Jul-02-24 Initiated JP Morgan
Overweight
$24
Jul-02-24 Initiated Goldman
Buy
$32
Jul-02-24 Initiated Evercore ISI
Outperform
$25
Jul-02-24 Initiated Deutsche Bank
Buy
$27
Jul-02-24 Initiated Canaccord Genuity
Buy
$30
Jul-02-24 Initiated BofA Securities
Buy
$27
Jul-02-24 Initiated Barclays
Overweight
$24
Sep-16-24 07:00AM
Aug-19-24 04:15PM
Aug-09-24 05:13PM
Aug-07-24 04:05PM
Jul-17-24 04:05PM
07:45AM
Loading…
Jul-05-24 07:45AM
Jul-01-24 08:58AM
Jun-27-24 05:17PM
Jun-07-24 04:09PM
03:56PM
(The Wall Street Journal)
Jun-06-24 06:15PM
05:32PM
02:50PM
12:42PM
Waystar Holding Corp. engages in the provision of healthcare organizations with mission-critical cloud software that simplifies healthcare payments. Its enterprise-grade platform streamlines the complex and disparate processes healthcare provider clients must manage to be reimbursed correctly, while improving the payments experience for providers, patients, and payers. The company was founded in 2000 and is headquartered in Lehi, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bridge T. Craig Chief Transformation Officer Jul 18 '24 Option Exercise 4.14 367,485 1,521,388 571,489 Jul 22 08:19 PM DRISCOLL JOHN PATRICK Chairperson Jun 10 '24 Buy 21.50 6,000 129,000 85,623 Jun 12 04:32 PM
Index S&P 500 P/E - EPS (ttm) -6.74 Insider Own 17.61% Shs Outstand 863.67M Perf Week -5.43%
Market Cap 7.52B Forward P/E 4.73 EPS next Y 1.84 Insider Trans 0.01% Shs Float 711.23M Perf Month -16.17%
Income -5811.00M PEG - EPS next Q 0.36 Inst Own 61.20% Short Float 11.66% Perf Quarter -45.46%
Sales 145.53B P/S 0.05 EPS this Y -28.35% Inst Trans -0.06% Short Ratio 3.83 Perf Half Y -58.12%
Book/sh 15.80 P/B 0.55 EPS next Y -35.41% ROA -6.40% Short Interest 82.91M Perf Year -60.12%
Cash/sh 0.81 P/C 10.70 EPS next 5Y - ROE -33.49% 52W Range 8.46 - 27.05 Perf YTD -66.64%
Dividend Est. 1.53 (17.56% ) P/FCF - EPS past 5Y - ROI -13.41% 52W High -67.80% Beta 0.68
Dividend TTM 1.23 (14.12% ) Quick Ratio 0.31 Sales past 5Y 0.68% Gross Margin 16.70% 52W Low 2.96% ATR (14) 0.39
Dividend Ex-Date Aug 21, 2024 Current Ratio 0.65 EPS Y/Y TTM -75.58% Oper. Margin 0.42% RSI (14) 32.94 Volatility 3.92% 4.30%
Employees 331000 Debt/Eq 2.47 Sales Y/Y TTM 6.92% Profit Margin -3.99% Recom 3.05 Target Price 11.50
Option/Short Yes / Yes LT Debt/Eq 2.18 EPS Q/Q 191.36% Payout - Rel Volume 2.12 Prev Close 8.98
Sales Surprise 1.14% EPS Surprise -7.48% Sales Q/Q 2.64% Earnings Jun 27 BMO Avg Volume 21.64M Price 8.71
SMA20 -5.23% SMA50 -16.17% SMA200 -50.03% Trades
Volume 45,885,602 Change -3.01%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade HSBC Securities
Hold → Reduce
Jan-03-24 Initiated Barclays
Underweight
$21
Dec-22-23 Initiated HSBC Securities
Hold
$27
Oct-23-23 Upgrade JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated Loop Capital
Buy
$45
Nov-23-22 Resumed Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed Credit Suisse
Neutral
$42
Apr-06-20 Upgrade UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Today 07:05AM
Sep-19-24 02:09PM
09:24AM
Sep-18-24 05:50PM
Sep-17-24 11:30PM
04:08PM
Loading…
04:08PM
Sep-16-24 01:21PM
10:40AM
07:52AM
(Pharmaceutical Business Review)
05:21AM
Sep-15-24 07:15AM
06:26AM
Sep-14-24 11:22AM
02:17AM
Sep-13-24 08:48PM
(Associated Press Finance)
08:24PM
Loading…
08:24PM
(The Wall Street Journal)
05:04PM
03:07PM
07:03AM
Sep-12-24 05:50PM
04:22AM
Sep-11-24 04:07PM
Sep-10-24 04:23PM
12:00PM
09:45AM
Sep-09-24 09:00AM
08:30AM
Sep-06-24 05:45PM
04:52PM
06:52AM
05:50PM
Loading…
Sep-05-24 05:50PM
04:15PM
09:00AM
09:00AM
08:19AM
06:30AM
Sep-03-24 02:40PM
09:00AM
05:24AM
Aug-31-24 03:27PM
08:30AM
06:40AM
06:00AM
Aug-30-24 05:17AM
Aug-29-24 08:15AM
Aug-28-24 04:26AM
Aug-27-24 05:36PM
04:01PM
01:58PM
08:02AM
Aug-26-24 06:08PM
05:45PM
02:45PM
05:41AM
Aug-24-24 07:42AM
Aug-23-24 07:25AM
Aug-22-24 01:19PM
Aug-21-24 05:23AM
Aug-20-24 07:56AM
07:44AM
06:33AM
05:15AM
04:06AM
Aug-19-24 12:44PM
08:00AM
Aug-18-24 10:16AM
Aug-17-24 05:15AM
Aug-16-24 05:45PM
04:46PM
12:21PM
09:00AM
08:48AM
05:45AM
05:00AM
Aug-14-24 01:28PM
Aug-13-24 05:45AM
Aug-12-24 08:06AM
Aug-11-24 08:06AM
Aug-08-24 05:54PM
04:54PM
09:30AM
05:02AM
Aug-07-24 05:48PM
08:11AM
04:56AM
Aug-06-24 09:25AM
Aug-05-24 05:48PM
05:04AM
Aug-04-24 01:12PM
08:27AM
(Associated Press Finance)
Aug-02-24 12:51PM
12:00PM
11:51AM
08:52AM
(Associated Press Finance)
Aug-01-24 06:19PM
06:08PM
09:00AM
08:00AM
Jul-30-24 05:06AM
Jul-29-24 03:58PM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM JARRETT VALERIE B Director Jan 29 '24 Buy 22.44 4,456 99,993 4,456 Jan 31 04:11 PM SCHLICHTING NANCY M Director Jan 16 '24 Sale 23.05 15,209 350,567 0 Jan 18 04:18 PM WENTWORTH TIMOTHY C Chief Executive Officer Jan 05 '24 Buy 24.22 10,000 242,220 585,122 Jan 08 07:29 AM Gates Richard P. SVP, Chief Pharmacy Officer Nov 10 '23 Sale 20.45 1,000 20,450 73,929 Nov 14 08:22 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 09 '23 Sale 195.38 1,279,590 249,999,896 30,489,956 Nov 14 07:15 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
